This indicates that the increased presence of the alternatively spliced ABI2 product due to hnRNP A1 dysfunction in MS and EAE leads to NMD and resultant decreased protein levels, implicating alternative splicing changes as part of the disease mechanism. The gene discussed is ABI2; the disease is myeloid sarcoma.